This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_URINARY_TRACT_EXALLC for full statistics.
Malignant neoplasm of urinary organs
C3_URINARY_TRACT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3755 |
6. Filter based on genotype QC (FinnGen only) |
3755 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of urinary organs
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3755 | 1330 | 2425 |
| Unadjusted period prevalence (%) | 0.85 | 0.45 | 1.07 |
| Median age at first event (years) | 67.08 | 66.19 | 67.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3461
- Matched controls
- 34608
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B01AB10
ATC
tinzaparin; parenteral
8.6
323.0
799
1170
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
2766.3
323.0
2842
56
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
1413
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
302.3
323.0
377
14
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1013
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
325
*
JN4AD
NOMESCO Finland
Body CT examination
7.4
323.0
887
1530
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
224.9
323.0
2034
218
KAC10
NOMESCO Finland
Total nephrectomy with capsule
544.8
323.0
837
20
KAD00
NOMESCO Finland
Partial nephrectomy
162.7
323.0
403
28
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
2908.7
323.0
734
*
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
432.9
323.0
630
18
197
Kela drug reimbursment
Sunitinib
1250.4
323.0
339
*
L01XE04
ATC
[U] sunitinib; oral
1522.2
289.5
278
*
130
Kela drug reimbursment
Malignant tumour
6.1
288.8
898
1877
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.9
260.5
1009
2679
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
27.8
258.3
360
144
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.1
245.8
600
876
JN4CD
NOMESCO Finland
Very extensive body CT
8.7
230.5
531
702
JN4BD
NOMESCO Finland
Extensive body CT
4.6
220.2
899
2463
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
125.9
219.3
235
20
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.4
211.8
616
1140
1502
Kela drug reimbursment
Cabozantinib
+∞
203.1
193
*
3012
Kela drug reimbursment
Cabozantinib
+∞
194.6
185
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.3
193.9
828
2335
C64.80
ICD-10 Finland
Wilms tumour
986.4
192.6
187
*
KAC00
NOMESCO Finland
Nephrectomy
128.1
191.5
205
17
U75
ICPC
Malignant neoplasm of kidney
227.4
168.8
173
8
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
25.6
168.1
239
100
159
Kela drug reimbursment
Pazopanib
340.7
163.5
164
5
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
160.4
1332
6152
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
159.6
152
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
13.3
154.5
280
228
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
152.2
145
*
7125
FHL
Nephrectomy (extrrafascial)
505.4
147.6
146
*
B01AB05
ATC
enoxaparin; parenteral
2.7
144.4
1444
7347
322
Kela drug reimbursment
Sunitinib
+∞
135.3
129
*
L01XE26
ATC
[U] cabozantinib; oral
+∞
128.9
123
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.8
128.0
344
554
UKC02
NOMESCO Finland
Cystoscopy
2.8
121.6
995
4395
R31
ICD-10 Finland
Unspecified haematuria
3.3
121.2
717
2546
L01XE11
ATC
[U] pazopanib; oral
301.8
114.8
116
*
8000/3-C64.9
ICD-O-3
Neoplasm, malignant of kidney, NOS
+∞
113.1
108
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
112.1
107
*
L01EX07
ATC
cabozantinib; oral
+∞
110.0
105
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
107.7
1769
11060
KAC20
NOMESCO Finland
Nephroureterectomy
110.0
107.7
117
11
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
48.1
106.5
130
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
106.0
1876
12098
180
Kela drug reimbursment
Interferon alfa
40.8
99.9
126
32
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.2
99.7
255
380
158
Kela drug reimbursment
Everolimus
257.3
98.2
100
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
93.9
456
1367
C66
ICD-10 Finland
Malignant neoplasm of ureter
59.5
88.4
104
18
WX402
NOMESCO Finland
General anaesthesia
2.7
88.0
704
2985
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.9
83.0
289
630
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.1
82.9
277
577
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.9
82.9
289
631
JN3AD
NOMESCO Finland
Abdominal CT examination
3.4
81.2
441
1436
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
77.5
852
4248
KA3LT
NOMESCO Finland
Njurlesion coagulation
202.0
76.5
79
*
168
Kela drug reimbursment
Axitinib
+∞
74.2
71
*
WZC30
NOMESCO Finland
Teaching
2.6
73.7
626
2717
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
67.5
1181
7134
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
77.8
67.3
76
10
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
660.4
66.1
65
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.3
64.7
360
1182
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
13.1
63.5
114
90
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
629.2
63.0
62
*
N02AA05
ATC
oxycodone; systemic
2.2
62.2
728
3688
L01XE10
ATC
[U] everolimus; oral
213.7
61.3
63
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.6
60.7
115
102
N02BE01
ATC
paracetamol; systemic, rectal
2.1
59.6
2933
25087
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
59.5
57
*
L01XE17
ATC
[U] axitinib; oral
+∞
55.3
53
*
Z51.5
ICD-10 Finland
Palliative care
2.9
54.9
357
1302
C648
ICD-10 Finland
NA
546.3
54.7
54
*
U14
ICPC
Kidney symptom/complaint
7.3
54.6
136
194
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
7.8
53.3
126
166
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
4.8
53.3
188
413
343
Kela drug reimbursment
Pazopanib
186.2
53.1
55
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
52.7
216
550
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.2
50.7
165
332
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
50.5
475
2142
C08CA01
ATC
amlodipine; oral
1.7
49.7
1451
10155
UKB02
NOMESCO Finland
Retrograde ureteroscopy
8.3
48.8
111
138
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.8
48.7
170
369
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
47.8
843
4976
L01EX01
ATC
sunitinib; oral
474.0
47.4
47
*
R4110
NOMESCO Finland
Physiotherapy
1.8
46.2
984
6193
8960/3-C64.9
ICD-O-3
Nephroblastoma, NOS, of kidney, NOS
+∞
44.9
43
*
TK800
NOMESCO Finland
Hemodialysis
4.8
44.5
155
336
A11CC03
ATC
alfacalcidol; systemic
4.6
44.3
160
360
340
Kela drug reimbursment
Everolimus
432.8
43.3
43
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.9
43.2
147
311
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
42.8
438
2049
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.5
40.9
152
352
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.9
40.6
83
86
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
39.4
688
4010
361
Kela drug reimbursment
Axitinib
+∞
38.6
37
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
37.8
288
1148
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
37.8
222
753
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
37.4
348
1550
205
Kela drug reimbursment
Chronic hypertension
1.6
36.4
1203
8498
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
12.0
35.3
65
55
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.4
34.8
131
308
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
16.9
34.5
55
33
ZXA05
NOMESCO Finland
Left side
1.7
34.0
947
6356
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
5.6
33.8
101
185
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
121.2
33.7
36
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
33.4
32
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
33.2
251
996
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
171.6
32.7
34
*
198
Kela drug reimbursment
Sorafenib
18.1
32.2
50
28
V03AE01
ATC
polystyrene sulfonate; oral
5.4
32.1
99
188
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
4.2
31.8
125
307
KCD02
NOMESCO Finland
Transurethral resection of bladder
3.4
31.7
162
496
KH1AD
NOMESCO Finland
CT of urinary organs
3.5
31.7
154
454
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
10.9
31.6
61
57
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
31.3
30
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
33.7
30.9
40
12
J01MA02
ATC
ciprofloxacin; systemic
1.5
30.6
1372
10330
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
24.1
30.5
43
18
S18
ICPC
Laceration/cut
1.5
30.5
1431
10891
A12AA04
ATC
calcium carbonate; oral
4.6
30.2
108
242
C03CA01
ATC
furosemide; systemic
1.5
29.3
1220
9003
WX704
NOMESCO Finland
Intubation
2.4
29.2
269
1188
H02AB02
ATC
dexamethasone; systemic
2.0
28.8
377
1952
SPAT1153
SPAT
Removal of sutures
1.6
28.8
1105
7988
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.9
28.8
122
321
M04AA01
ATC
allopurinol; systemic
1.8
28.7
594
3619
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
6.1
28.7
79
131
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
151.2
28.7
30
*
WW500
NOMESCO Finland
Blood transfusion
2.8
28.7
190
697
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.4
28.2
86
162
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
28.2
2137
17944
N28.1
ICD-10 Finland
Cyst of kidney
4.8
28.0
95
202
Z49.0
ICD-10 Finland
Preparatory care for dialysis
6.3
27.9
75
121
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.7
27.3
199
774
ZXA00
NOMESCO Finland
Right side
1.6
27.1
966
6838
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
75.7
26.8
30
*
L03AA04
ATC
NA
18.4
26.1
40
22
8010/3-C64.9
ICD-O-3
Carcinoma, NOS, of kidney, NOS
+∞
26.1
25
*
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
4.9
26.0
87
182
L01XE05
ATC
[U] sorafenib; oral
20.2
25.6
38
19
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
6.8
25.3
64
95
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
25.3
582
3655
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.0
25.2
82
167
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
20.8
25.2
37
18
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
25.1
499
2992
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
25.0
210
882
R50.9
ICD-10 Finland
Fever, unspecified
1.8
24.9
477
2827
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
130.9
24.6
26
*
Z90.5
ICD-10 Finland
Acquired absence of kidney
48.7
24.3
29
6
WX110
NOMESCO Finland
Local anesthesy
1.4
24.1
1970
16521
N18.0
ICD-10 Finland
End-stage renal disease
4.7
23.8
82
178
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
41.7
23.6
29
7
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.6
23.5
55
73
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.5
23.5
84
189
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
23.5
453
2688
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
33.6
23.3
30
9
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.6
23.3
45
43
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
9.0
23.2
49
55
B03XA02
ATC
darbepoetin alfa; parenteral
3.7
23.2
104
289
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.1
23.0
73
145
J01MA12
ATC
levofloxacin; systemic
1.6
22.9
668
4469
L01EX03
ATC
pazopanib; oral
231.4
22.6
23
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
22.3
996
7357
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
35.3
22.0
28
8
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
13.2
21.9
38
29
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
4.8
21.6
72
151
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
3.3
21.5
111
345
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
21.5
599
3948
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
5.1
21.5
68
135
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
23.3
21.2
30
13
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
20.9
193
853
L03AB04
ATC
interferon alfa-2a; parenteral
16.6
20.9
33
20
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.3
20.9
108
336
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
4.2
20.8
80
194
U06
ICPC
Haematuria
3.0
20.4
119
403
XKD00
NOMESCO Finland
Uroflowmetry
1.5
20.3
703
4888
C02AC05
ATC
moxonidine; oral
2.3
20.1
193
870
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
20.0
175
752
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
19.8
19
*
7126
FHL
Nephroureterectomy
+∞
19.8
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.2
19.8
210
989
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
73.9
19.7
22
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
105.6
19.6
21
*
ZXC96
NOMESCO Finland
Robot assisted procedure
3.1
19.5
112
375
M05BX04
ATC
denosumab; parenteral
2.3
19.2
184
829
ZX120
NOMESCO Finland
Intravenous
1.8
18.9
327
1868
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
15.9
18.8
30
19
L01EK01
ATC
axitinib; oral
+∞
18.8
18
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
18.7
387
2340
U79
ICPC
Neoplasm urinary tract unspecified
38.6
18.5
23
6
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
18.1
558
3760
L03AB05
ATC
interferon alfa-2b; parenteral
8.9
18.1
38
43
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
17.8
169
758
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.4
17.6
64
148
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
17.6
213
1063
C08CA02
ATC
felodipine; oral
1.7
17.6
367
2224
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.4
17.5
52
97
137
Kela drug reimbursment
Uraemia requiring dialysis
5.3
17.4
53
102
A02BC02
ATC
pantoprazole; systemic
1.4
16.9
2037
17737
M907, C6488
ICD-10 Finland
NA
+∞
16.7
16
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.3
16.6
50
95
J01DB01
ATC
cefalexin; oral
1.4
16.5
2494
22493
Z31.5
ICD-10 Finland
Genetic counselling
2.8
16.4
109
402
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.2
16.2
85
270
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
24.6
16.0
22
9
8120/3-C68.0
ICD-O-3
Transitional cell carcinoma, NOS, of urethra
+∞
15.6
15
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.6
15.6
69
192
RJ128
NOMESCO Finland
NA
11.7
15.5
28
24
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.8
15.4
65
174
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
8.3
15.2
33
40
A04AA01
ATC
ondansetron; systemic, rectal
2.0
15.2
208
1093
A04AA02
ATC
granisetron; systemic, transdermal
2.0
15.1
197
1015
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.9
15.1
37
54
C08CA13
ATC
lercanidipine; oral
1.6
15.0
450
3002
B02AA02
ATC
tranexamic acid; systemic
1.7
15.0
323
1970
Z94.0
ICD-10 Finland
Kidney transplant status
4.3
14.9
54
126
A10BH05
ATC
linagliptin; oral
2.0
14.8
197
1024
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
14.6
14
*
J01EA01
ATC
trimethoprim; systemic
1.4
14.5
692
5110
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
5.4
14.5
43
81
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.8
14.5
93
336
B05DA
ATC
Isotonic solutions
5.6
14.3
41
74
V03AE02
ATC
sevelamer; oral
6.6
14.3
36
55
H05BX01
ATC
cinacalcet; oral
5.9
14.2
39
67
A06AD11
ATC
lactulose; oral
1.5
14.2
522
3650
N99.0
ICD-10 Finland
Postprocedural renal failure
23.8
13.8
19
8
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
8.6
13.7
29
34
WX290
NOMESCO Finland
Other blockade of nerve
1.4
13.7
979
7757
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
+∞
13.5
13
*
G04CA02
ATC
tamsulosin; oral
1.4
13.5
984
7819
N18
ICD-10 Finland
Chronic kidney disease
3.9
13.4
54
140
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
12.9
571
4144
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.2
12.8
130
603
Z49.2
ICD-10 Finland
Other dialysis
5.3
12.8
38
72
WX882
NOMESCO Finland
High dependency care
2.4
12.8
109
467
B03XA01
ATC
erythropoietin; parenteral
4.0
12.6
49
123
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
8.7
12.5
26
30
WF004
NOMESCO Finland
Palliative radiotherapy
2.6
12.4
86
330
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.0
12.3
48
121
R33
ICD-10 Finland
Retention of urine
1.6
12.3
322
2073
B01AB04
ATC
dalteparin; parenteral
1.9
12.1
169
895
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
18.1
12.0
18
10
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
3.3
12.0
59
181
196
Kela drug reimbursment
Paricalcitol and cinacalcet
6.0
11.9
32
54
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
11.9
202
1145
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.6
11.9
84
326
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
5.9
11.8
32
55
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
11.7
313
2025
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.3
11.7
102
442
7124
FHL
Nephrectomy (simple
30.1
11.6
15
5
127
Kela drug reimbursment
Transplant complication
3.3
11.6
58
180
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
11.5
206
1187
8000/3-C65.9
ICD-O-3
Neoplasm, malignant of renal pelvis
+∞
11.5
11
*
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
11.5
11
*
1891C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,MUU/TARK MÄÄR SYÖPÄ]
+∞
11.5
11
*
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
7.5
11.4
26
35
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.1
11.3
122
583
L04AA06
ATC
mycophenolic acid; systemic
3.1
11.3
60
195
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
7.3
11.2
26
36
E83.50
ICD-10 Finland
Hypercalcemia
3.4
11.2
52
153
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.4
11.2
39
89
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.6
11.2
82
325
KBD00
NOMESCO Finland
Partial excision of ureter
25.1
11.1
15
6
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
20.1
11.1
16
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
11.1
297
1926
E87.5
ICD-10 Finland
Hyperkalaemia
2.7
11.1
75
285
C07AB02
ATC
metoprolol; systemic
1.4
11.0
741
5781
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
10.0
11.0
21
21
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
5.0
10.9
34
69
321
Kela drug reimbursment
Paricalcitol and cinacalcet
5.0
10.9
34
69
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
43.4
10.9
13
*
JN6AD
NOMESCO Finland
CT of torso and neck
3.4
10.9
51
151
C09AA02
ATC
enalapril; systemic
1.4
10.9
698
5403
N30.0
ICD-10 Finland
Acute cystitis
1.5
10.9
348
2353
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
6.0
10.9
29
49
N19
ICD-10 Finland
Unspecified kidney failure
2.0
10.8
139
716
B05DB
ATC
Hypertonic solutions
5.2
10.7
32
62
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
21.5
10.7
15
7
R4190
NOMESCO Finland
Nutritional therapy
2.3
10.6
97
431
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
60.2
10.6
12
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.8
10.5
34
72
KA3GB
NOMESCO Finland
Retrograde pyelography
10.0
10.5
20
20
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.7
10.5
71
270
ZX136
NOMESCO Finland
Intravesicalis
3.9
10.5
41
105
8000/3-C68.9
ICD-O-3
Neoplasm, malignant of urinary system, NOS
+∞
10.4
10
*
8130/3-C65.9
ICD-O-3
Papillary urothelial carcinoma of renal pelvis
+∞
10.4
10
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.2
10.4
99
450
JLC10
NOMESCO Finland
Distal pancreatectomy
7.7
10.4
23
30
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.4
10.3
49
147
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
5.5
10.2
29
53
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
10.1
307
2049
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.2
10.1
96
436
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
10.0
979
8057
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
26.1
9.8
13
5
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
20.1
9.8
14
7
TK820
NOMESCO Finland
Peritoneal dialysis
5.7
9.8
27
48
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
4.8
9.7
31
65
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.7
496
3686
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
6.1
9.7
25
41
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.3
9.6
47
145
A79
ICPC
Malignancy NOS
3.0
9.6
55
187
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
9.6
264
1720
C09CA01
ATC
losartan; oral
1.3
9.6
743
5907
H02AB06
ATC
prednisolone; systemic
1.3
9.5
1373
11860
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
9.5
329
2263
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
6.6
9.4
23
35
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
+∞
9.4
9
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
9.4
162
928
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
8.0
9.3
20
25
JAH00
NOMESCO Finland
Laparotomy
2.1
9.3
96
455
C09BA02
ATC
enalapril and diuretics; systemic
1.5
9.1
296
2006
WW200
SPAT
NA
0.5
9.1
83
1550
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
6.2
9.1
23
37
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
15.6
9.0
14
9
105
Kela drug reimbursment
Adrenal cortical hypofunction
10.0
9.0
17
17
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
9.0
423
3097
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
24.1
8.9
12
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.8
874
7181
WX892
NOMESCO Finland
Monitored bed care
1.6
8.8
254
1675
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.8
1270
10938
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
8.6
8.8
18
21
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
5.9
8.7
23
39
1530
FHL
Urethrocystoscopy
2.3
8.7
77
340
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.6
8.7
61
239
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
4.6
8.6
28
61
N05CF01
ATC
zopiclone; oral
1.3
8.6
977
8172
GDA20
NOMESCO Finland
Excision of lesion of lung
11.6
8.6
15
13
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.9
8.5
20
29
PC5SC
NOMESCO Finland
Selective angiography of kidney artery with X-ray
10.0
8.5
16
16
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.5
8.5
62
247
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.8
8.5
132
731
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
3.1
8.5
44
143
D30.1
ICD-10 Finland
Benign neoplasm: Renal pelvis
27.6
8.5
11
*
7121
FHL
Removal of local change or renal resection (eg cyst)
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
XX9XW
NOMESCO Finland
NA
3.8
8.3
33
87
OAB42
NOMESCO Finland
Guidance related to known health problem
5.2
8.3
24
46
JMA10
NOMESCO Finland
Transabdominal total splenectomy
4.0
8.2
31
78
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
2.8
8.2
50
181
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
14.5
8.2
13
9
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
5.4
8.1
23
43
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.8
8.1
48
170
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.1
8.1
90
442
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
17.2
8.1
12
7
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
11.7
8.1
14
12
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
8.9
8.0
16
18
KBB00
NOMESCO Finland
Biopsy of ureter
22.1
8.0
11
5
N43.3
ICD-10 Finland
Hydrocele, unspecified
2.2
8.0
76
347
J01CA04
ATC
amoxicillin; systemic
1.2
7.9
2288
21170
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
7.9
395
2920
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
4.9
7.9
24
49
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
6.6
7.9
19
29
H02AB09
ATC
hydrocortisone; systemic
2.5
7.9
61
251
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
6.1
7.8
20
33
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
7.8
112
604
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.8
7.7
120
666
Z80.5
ICD-10 Finland
Family history of malignant neoplasm of urinary tract
45.1
7.7
9
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
7.7
152
911
A06AH03
ATC
naloxegol; oral
2.9
7.7
45
159
C07AB07
ATC
bisoprolol; oral
1.2
7.6
1599
14275
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
7.6
84
410
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
7.6
123
692
N02AA01
ATC
morphine; systemic, rectal
2.5
7.6
56
224
PJD99
NOMESCO Finland
Excision of other lymph nodes
18.4
7.6
11
6
3025
Kela drug reimbursment
Calcium carbonate
8.0
7.6
16
20
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
4.2
7.6
27
65
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.4
7.6
34
100
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
7.6
938
7906
UJF32
NOMESCO Finland
Coloscopy
1.3
7.6
773
6363
N03AX16
ATC
pregabalin; oral
1.3
7.5
652
5250
C09DA01
ATC
losartan and diuretics; oral
1.4
7.5
311
2224
N20.1
ICD-10 Finland
Calculus of ureter
1.8
7.4
121
681
KBV10
NOMESCO Finland
Removal of stent from ureter
3.7
7.4
30
81
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
80.2
7.4
8
*
E66.8
ICD-10 Finland
Other obesity
2.0
7.4
95
492
P01AB01
ATC
metronidazole; oral, rectal
1.2
7.3
985
8369
C68
ICD-10 Finland
Malignant neoplasm of other and unspecified urinary organs
+∞
7.3
7
*
D30.2
ICD-10 Finland
Benign neoplasm: Ureter
+∞
7.3
7
*
KAC96
NOMESCO Finland
Other nephrectomy
+∞
7.3
7
*
8070/3-C68.0
ICD-O-3
Squamous cell carcinoma, NOS, of urethra
+∞
7.3
7
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
6.8
7.3
17
25
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
9.4
7.3
14
15
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
7.3
193
1251
KC1GB
NOMESCO Finland
Cystography with X-ray
2.9
7.3
40
137
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
7.2
220
1472
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
7.2
89
456
KWW96
NOMESCO Finland
Other reoperation in urological surgery
30.1
7.1
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
7.0
218
1467
M10.9
ICD-10 Finland
Gout, unspecified
1.5
7.0
235
1609
GDB10
NOMESCO Finland
Wedge resection of lung
7.0
7.0
16
23
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
5.1
6.9
20
39
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
5.8
6.9
18
31
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
6.9
329
2414
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.3
6.9
58
252
SPAT1254
SPAT
Administration of medicine
1.3
6.8
432
3322
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
10.9
6.8
12
11
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.4
6.8
269
1906
NK6AN
NOMESCO Finland
Total body bone isotope imaging
1.8
6.8
102
560
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
6.8
112
638
C67
ICD-10 Finland
Malignant neoplasm of bladder
5.3
6.8
19
36
PC5NT
NOMESCO Finland
Endovascular embolisation for kidney bleeding with radiological guidance
40.1
6.8
8
*
D41.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urethra
16.7
6.7
10
6
J01CA08
ATC
pivmecillinam; oral
1.3
6.6
798
6688
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
6.6
138
841
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.6
566
4547
N28.8
ICD-10 Finland
Other specified disorders of kidney and ureter
5.5
6.6
18
33
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.6
6.6
27
75
SPAT1263
SPAT
Sampling
1.2
6.5
1161
10150
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.1
6.5
23
56
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.8
6.5
39
142
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
3.6
6.5
27
76
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
6.4
532
4252
XX6LT
NOMESCO Finland
Coagulation of tumour with radiological guidance
70.0
6.4
7
*
PHC70
NOMESCO Finland
Suture of inferior vena cava
70.0
6.4
7
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.1
6.4
32
104
S15
ICPC
Foreign body in skin
1.6
6.3
161
1035
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.3
1280
11323
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
3.0
6.3
33
111
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
6.2
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.2
6
*
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.2
6
*
1899X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]
+∞
6.2
6
*
KCB00
NOMESCO Finland
Biopsy of bladder
4.3
6.2
21
49
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
6.2
495
3937
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.1
6.2
62
294
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
6.2
45
183
A10AE04
ATC
insulin glargine; parenteral
1.4
6.2
280
2036
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
4.0
6.1
22
55
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.4
6.0
48
205
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
8.6
6.0
12
14
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
10.0
6.0
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
877
3256
3.21
178.68
9.2
7.1
11.6
10.8
mmol/l
2.42
827
3077
2292
14190
2.58
168.36
5.2
4.2
—
—
—
0
0
599
1931
3.50
151.72
8.1
9.8
—
—
—
0
0
1023
4502
2.75
150.07
8.9
5.9
1.1
1.0
mmol/l
5.97
962
4154
2221
14095
2.41
146.14
8.0
4.9
34.1
34.7
g/l
6.01
2089
13024
894
3756
2.81
142.60
7.3
7.4
96.6
95.3
%
10.57
861
3606
838
3412
2.87
141.73
7.7
7.8
119.3
121.0
g/l
1.71
818
3276
931
4158
2.65
130.36
7.3
7.1
-0.2
1.1
mmol/l
20.52
737
3210
2256
14844
2.30
130.27
10.4
6.2
1.2
1.2
mmol/l
0.06
2129
13370
931
4164
2.64
129.93
7.3
7.1
5.2
5.1
kpa
6.72
896
3950
930
4164
2.64
129.45
7.2
7.1
13.5
11.9
kpa
15.17
894
3951
1707
10129
2.26
125.13
5.1
3.5
107.6
88.0
e6/l
0.34
1474
7921
964
4480
2.55
123.51
8.6
6.7
104.8
104.4
mmol/l
2.46
950
4351
2768
20159
2.42
121.65
6.6
4.9
554.4
1474.8
e6/l
1.02
40
363
1323
7136
2.32
121.11
3.7
2.7
3.6
4.6
e6/l
3.49
1201
6261
1579
9213
2.23
119.06
4.9
3.3
0.3
0.5
e6/l
1.38
1349
7046
885
4143
2.49
110.12
4.4
4.2
236.1
244.8
u/l
0.94
860
3898
2332
16330
2.13
104.94
12.0
7.0
1.2
1.2
mmol/l
0.70
1965
13725
1794
11409
2.10
104.34
5.8
3.9
95.1
114.2
e6/l
0.39
1519
8404
2317
16432
2.07
97.51
11.6
6.3
10.6
12.4
umol/l
7.88
2238
15581
1309
7635
2.10
93.41
2.9
2.5
—
—
—
0
0
503
1919
2.87
93.25
8.6
9.1
23.3
24.4
mmol/l
13.18
485
1776
2972
23588
2.25
87.31
14.3
7.7
83.1
80.8
u/l
1.75
2889
22103
2044
14227
1.96
86.21
11.2
10.9
1.2
1.3
inr
6.07
571
3887
2512
18852
2.00
83.92
7.1
5.0
6.9
6.9
mmol/l
0.15
2425
17775
996
5421
2.14
83.71
4.6
3.2
0.8
0.8
mmol/l
0.21
949
5028
667
3117
2.39
80.87
7.9
6.8
1.2
1.4
mmol/l
11.51
648
2993
567
2503
2.49
77.73
6.0
3.9
136.1
97.5
ng/l
8.84
500
2122
951
5347
2.04
71.65
4.5
3.2
1.8
1.7
e6/l
0.02
610
3029
2304
17267
1.86
71.46
14.0
8.8
4.4
4.3
e9/l
0.68
2045
14951
988
5677
2.00
69.78
4.2
3.0
0.9
1.2
e6/l
0.80
645
3330
1581
10717
1.82
66.39
6.6
3.4
2.4
2.3
mmol/l
2.18
1422
9166
1475
9815
1.83
65.63
4.2
2.6
65.7
59.1
u/l
1.62
1392
9020
536
2569
2.27
59.98
5.1
2.2
396.9
371.0
nmol/l
2.29
516
2333
1210
7950
1.77
53.59
5.4
4.1
90.5
84.4
%
12.76
1189
7764
897
5392
1.87
53.26
2.2
2.0
29.9
30.1
s
0.44
890
5223
796
4675
1.89
50.47
4.0
2.6
20.3
22.5
%
4.90
674
3974
877
5317
1.85
50.28
3.8
2.6
10.7
12.6
umol/l
12.10
822
4920
831
4957
1.87
50.15
3.9
2.6
2.1
2.3
g/l
13.48
781
4578
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
319
1312
2.56
49.87
2.8
2.7
0.4
0.3
u/ml
0.67
153
751
234
824
2.96
49.32
4.6
3.3
1.9
1.7
mg/l
2.82
213
740
970
6141
1.78
47.83
5.8
3.1
2.5
2.5
mmol/l
6.21
875
5325
170
508
3.46
47.10
1.5
1.4
16.7
8.6
u/l
5.43
131
405
353
1690
2.20
38.84
7.1
3.9
23.7
24.1
mmol/l
2.04
326
1502
440
2302
2.03
38.35
7.1
6.7
24.2
24.4
mmol/l
0.86
416
2145
586
3380
1.87
38.29
6.3
3.7
1.2
2.0
mmol/l
4.96
472
2695
582
3385
1.85
36.94
6.2
3.7
5.9
5.8
kpa
0.32
566
3271
1848
14470
1.55
36.46
5.2
3.8
0.0
0.0
estimate
0.50
447
2682
205
792
2.68
36.21
6.3
7.1
105.8
105.3
mmol/l
1.22
186
703
1914
15125
1.54
36.05
6.8
5.8
1.8
1.9
e9/l
0.21
1672
13118
1934
15349
1.54
35.49
7.0
5.9
0.2
0.2
e9/l
0.66
1689
13278
1861
14661
1.53
35.24
5.3
3.9
0.0
0.0
estimate
0.19
447
2612
1815
14276
1.53
34.26
7.1
6.2
24.8
26.2
%
5.49
1700
13156
1779
13964
1.52
33.70
7.0
6.0
2.9
2.9
%
0.05
1678
12913
1831
14481
1.52
33.33
6.9
5.2
0.0
0.0
estimate
0.00
452
2714
1185
8564
1.56
32.54
3.6
2.9
3011.4
5908.3
umol/l
1.72
1024
7270
1781
14058
1.51
32.37
6.9
5.9
59.8
58.3
%
5.18
1678
13033
1262
9288
1.54
31.75
4.7
3.2
31.6
38.6
u/l
2.40
1208
8779
106
322
3.36
28.66
1.5
1.3
—
—
nmol/l
—
0
0
119
392
3.10
28.17
1.7
1.4
34.7
30.6
iu/l
0.50
84
326
424
2462
1.81
26.54
1.8
1.6
—
—
—
0
0
112
369
3.10
26.52
1.6
1.3
0.7
0.7
nmol/l
0.11
107
348
502
3079
1.73
26.00
3.0
2.6
65.7
66.1
g/l
0.41
461
2783
823
5739
1.56
25.42
1.9
1.9
—
—
—
0
0
110
371
3.02
25.03
1.6
1.3
0.2
0.3
nmol/l
0.53
11
27
1338
10395
1.45
24.05
3.6
3.2
7.1
7.5
mmol/l
3.85
1099
8611
63
151
4.23
23.98
1.3
1.3
37.6
28.3
u/l
1.02
58
118
1411
11084
1.44
23.83
5.7
4.2
—
—
—
0
0
547
3523
1.65
23.41
4.3
3.7
—
—
—
0
0
379
2207
1.80
23.39
5.0
3.7
1.1
1.9
mmol/l
3.53
268
1598
558
3631
1.63
22.88
3.0
4.0
11.8
21.3
ug/l
0.90
447
3014
1304
10173
1.43
22.54
3.7
3.3
568.1
289.8
mg/l
1.33
892
6606
390
2322
1.76
22.28
5.1
3.8
5.1
5.2
kpa
0.13
362
2133
2499
21869
1.43
22.17
4.9
4.1
18.9
13.8
mm/h
24.87
2304
20032
36
58
6.26
21.44
10.4
2.3
73.9
44.3
u/l
0.80
20
16
172
787
2.24
21.02
5.1
4.9
2.5
2.6
mmol/l
0.30
114
536
1353
10739
1.41
20.77
4.5
4.0
23.9
9.1
mg/mmol
10.35
910
6929
276
1521
1.88
20.29
5.6
5.1
1.7
1.6
%
1.01
255
1425
527
3477
1.60
20.26
3.1
2.8
7.9
9.5
umol/l
1.19
470
3061
272
1495
1.88
20.16
5.7
5.2
1.0
0.9
%
3.74
251
1400
1048
7999
1.43
19.89
5.9
4.2
0.0
0.0
estimate
0.52
404
2551
478
3096
1.62
19.80
2.0
2.2
0.2
0.2
g/l
2.59
446
2869
431
2738
1.65
19.27
7.4
4.0
1.2
1.2
mmol/l
0.35
400
2384
618
4294
1.53
18.79
2.6
2.5
1.7
1.8
%
0.49
560
3758
254
1399
1.87
18.70
4.5
3.1
4.2
4.4
pmol/l
1.45
227
1211
301
1760
1.77
18.22
1.7
1.7
1.9
1.5
g/l
4.57
251
1503
578
3988
1.53
18.11
1.8
1.8
—
—
—
0
0
234
1278
1.89
17.68
2.8
3.2
11942.7
2104.9
u/ml
0.43
202
1102
573
3984
1.52
17.26
1.8
1.8
—
—
—
0
0
1430
11707
1.36
17.26
3.7
2.8
219.0
164.9
ug/l
6.33
1296
10627
428
2793
1.60
17.08
4.7
3.1
4.8
4.5
kpa
1.32
412
2691
132
601
2.24
16.38
3.9
5.3
795.5
3149.3
iu/ml
0.45
15
89
430
2851
1.57
16.00
3.1
2.4
66.2
39.6
u/l
0.43
390
2428
265
1580
1.73
14.96
2.0
1.9
1.6
2.4
ug/l
0.94
236
1386
471
3233
1.52
14.95
2.9
2.5
65.7
68.9
e9/l
1.18
359
2474
120
546
2.24
14.94
1.4
1.8
2.3
4.5
iu/l
3.96
31
166
1061
8447
1.36
14.81
2.3
2.3
3.3
3.0
mg/l
2.46
906
7158
115
519
2.25
14.61
1.4
1.5
1444.8
1820.4
e6/l
0.53
80
377
382
2543
1.56
13.90
4.2
2.8
47.4
61.8
ml/min/173m2
20.34
240
1066
124
591
2.14
13.79
1.5
1.5
32.5
31.2
g/l
0.53
110
533
144
727
2.02
13.73
1.3
1.2
—
—
—
0
0
103
468
2.23
12.92
2.0
1.9
20.6
24.1
ug/l
0.43
97
460
3096
28983
1.39
12.73
27.1
16.9
35.7
26.8
mg/l
30.89
2875
23643
148
779
1.94
12.56
3.3
2.5
16.4
16.0
%
0.63
87
405
103
475
2.20
12.47
1.3
1.4
77965.3
75441.3
e6/l
0.02
57
291
159
867
1.87
12.13
2.2
2.4
4.0
3.6
g/l
1.38
154
821
162
892
1.85
11.99
3.5
3.3
8.2
8.0
kpa
0.89
153
826
806
6333
1.35
11.85
1.7
1.7
1.6
1.5
mg/l
0.57
653
4953
1501
12842
1.28
11.79
4.7
4.1
46.0
90.4
ng/l
0.75
1227
9839
1520
13027
1.28
11.77
16.0
10.4
0.0
0.0
e9/l
0.98
1242
10603
229
1402
1.67
11.75
5.9
4.1
24.2
24.8
mmol/l
2.23
214
1279
183
1064
1.76
11.33
1.3
1.3
—
—
—
0
0
201
1205
1.71
11.16
2.5
3.3
1.4
3.1
ratio
1.37
13
89
170
974
1.78
11.07
3.8
3.3
23.5
25.0
mmol/l
4.37
155
841
41
127
3.25
10.93
25.8
27.3
82.9
119.2
ug/l
5.47
35
109
33
90
3.69
10.67
1.8
2.3
—
—
—
0
0
203
1238
1.68
10.59
2.5
3.3
60.3
107.2
mg/l
0.51
166
999
19
33
5.78
10.53
4.4
5.6
64.4
49.0
ug/min
0.45
19
27
202
1237
1.67
10.38
2.5
3.3
81.7
64.8
mg/l
0.26
164
1003
78
347
2.27
10.36
1.3
1.4
225.5
276.9
pmol/l
1.13
65
261
211
1314
1.64
10.16
1.3
1.2
156.3
132.7
iu/ml
0.31
64
450
204
1263
1.65
10.05
2.5
2.6
—
—
—
0
0
181
1099
1.68
9.62
4.9
3.9
4.0
3.9
mmol/l
2.07
171
1013
303
2083
1.49
9.46
1.5
1.5
—
—
—
0
0
318
2214
1.48
9.33
4.9
3.2
118.1
128.2
g/l
10.99
313
2149
49
186
2.66
9.18
1.8
2.2
—
—
—
0
0
1368
11839
1.24
9.03
2.6
2.2
79.8
78.5
nmol/l
0.78
1227
10358
108
577
1.90
8.87
3.5
3.4
60.3
58.7
%
0.61
108
577
111
599
1.88
8.84
1.2
1.6
—
—
—
0
0
19
39
4.89
8.83
4.3
5.6
—
—
—
0
0
136
782
1.77
8.82
1.3
1.6
—
—
—
0
0
49
192
2.57
8.64
1.8
2.2
18.4
15.3
%
0.32
14
80
165
1009
1.66
8.57
2.0
1.7
—
—
—
0
0
68
313
2.19
8.40
1.2
1.3
16.3
13.4
u/l
0.29
59
288
133
773
1.75
8.33
2.2
2.4
222.3
202.2
%
1.63
128
737
139
819
1.72
8.30
1.3
1.6
—
—
—
0
0
143
850
1.71
8.27
2.1
2.2
89.9
88.0
%
0.48
137
810
150
904
1.69
8.24
2.6
2.3
213.1
89.5
ug/min
2.00
95
545
137
808
1.72
8.15
3.1
2.1
128.9
127.9
g/l
0.15
110
591
137
811
1.72
8.05
1.3
1.5
—
—
—
0
0
71
343
2.09
7.78
3.7
2.9
—
—
—
0
0
259
1797
1.47
7.75
5.3
3.4
24.1
25.2
mmol/l
5.25
253
1740
786
6478
1.27
7.73
6.0
4.3
1.0
1.0
kg/l
0.08
139
995
190
1235
1.57
7.72
2.4
2.2
491.9
684.9
ug/l
0.45
184
1168
304
2178
1.43
7.68
1.9
1.7
—
—
—
0
0
814
6753
1.26
7.56
4.8
4.0
1321.5
451.5
ng/l
0.39
703
5761
1251
10900
1.22
7.36
3.2
3.2
2418.0
1731.9
ng/l
3.49
1124
9475
1159
10043
1.22
7.16
2.1
2.2
199.5
230.4
u/l
0.57
1089
9356
2269
20973
1.21
7.09
6.4
3.7
15.2
15.0
pmol/l
2.56
2065
18684
89
483
1.86
7.04
1.2
1.5
—
—
—
0
0
43
176
2.46
6.99
2.1
1.5
2.5
3.6
u/field
0.36
28
128
100
566
1.79
6.92
1.3
1.4
—
—
—
0
0
62
301
2.08
6.76
1.3
1.3
—
—
—
0
0
121
729
1.68
6.73
1.7
2.8
27.7
35.8
umol/l
3.63
87
610
78
412
1.91
6.72
1.4
1.4
6.4
6.4
mmol/l
0.02
72
384
61
298
2.06
6.55
2.0
2.2
715.5
637.7
ml
0.81
45
182
85
471
1.82
6.34
6.0
6.5
12.1
12.3
mg/l
0.14
75
436
73
387
1.90
6.25
1.3
1.6
—
—
—
0
0
140
895
1.59
6.18
1.4
1.6
—
—
—
0
0
207
1442
1.46
6.12
1.7
2.4
4.0
3.8
g/l
0.83
145
1031
207
1443
1.46
6.10
1.7
2.4
—
—
—
0
0
207
1444
1.46
6.08
1.7
2.4
7.8
7.4
g/l
1.91
149
1067
81
450
1.82
6.01
1.2
1.4
—
—
—
0
0
1936
17788
1.18
5.96
3.5
3.2
61.6
56.8
u/l
1.21
1778
16236
83
467
1.79
5.91
2.0
1.4
109.0
119.3
u/ml
0.41
28
89
193
1336
1.47
5.91
1.8
2.4
3.3
3.1
g/l
2.10
147
1050
88
505
1.76
5.87
1.3
1.4
—
—
—
0
0
44
199
2.23
5.78
6.8
4.9
28.8
36.7
u/ml
0.15
13
55
23
76
3.04
5.64
1.2
1.1
393.6
266.3
pmol/l
0.43
15
52
19
56
3.40
5.58
1.2
1.2
2014.9
631.3
u/l
0.30
13
40
193
1355
1.45
5.51
1.7
2.4
10.9
10.3
g/l
0.86
159
1144
17
47
3.63
5.47
1.8
1.8
1.4
3.2
ug/l
1.12
12
27
40
179
2.25
5.41
2.2
1.8
—
—
—
0
0
56
286
1.97
5.39
1.2
1.6
—
—
—
0
0
139
917
1.54
5.39
1.4
1.5
246.2
266.7
ug/g
0.63
88
555
80
461
1.75
5.30
1.2
1.4
—
—
—
0
0
48
240
2.01
4.93
1.2
1.2
—
—
—
0
0
174
1228
1.44
4.87
2.0
2.5
1.4
1.1
g/l
0.30
153
1046
117
764
1.55
4.79
2.7
3.4
30.6
865.2
u/ml
1.61
105
708
19
62
3.07
4.78
1.0
1.1
0.7
0.7
umol/24h
—
10
34
18
57
3.17
4.76
2.0
1.6
185.2
160.6
ng/l
0.24
18
57
146
1004
1.47
4.69
3.6
3.8
51.3
73.1
u/ml
0.86
137
964
187
1350
1.41
4.63
2.1
1.8
—
—
—
0
0
61
342
1.80
4.49
1.4
1.6
—
—
—
0
0
2450
23207
1.16
4.43
35.4
20.5
14.2
13.9
%
28.26
2410
22651
100
643
1.57
4.41
1.6
1.3
—
—
—
0
0
80
489
1.65
4.34
1.2
1.2
—
—
—
0
0
29
125
2.33
4.33
1.2
1.3
423.1
401.7
ug/l
—
9
65
198
1462
1.37
4.31
2.1
2.0
—
—
—
0
0
30
132
2.28
4.28
1.3
3.9
64.8
63.0
mg/l
0.05
22
90
78
477
1.65
4.23
1.1
1.1
—
—
—
0
0
104
683
1.54
4.20
1.4
1.4
—
—
—
0
0
152
1078
1.43
4.19
1.6
2.3
0.0
0.0
g/l
0.76
141
978
143
1008
1.44
4.08
1.6
2.3
0.0
0.0
g/l
0.50
133
913
141
993
1.44
4.05
1.6
2.3
0.0
0.0
g/l
0.00
133
912
54
302
1.80
4.04
1.2
1.2
71.5
58.7
u/l
0.31
38
209
36
179
2.02
3.83
1.6
1.6
4.0
6.6
u/l
0.61
22
87
3150
30552
1.19
3.80
34.9
20.0
139.0
139.6
mmol/l
31.89
3097
29738
155
1126
1.39
3.76
1.7
2.2
36.1
37.4
g/l
1.97
137
960
24
102
2.36
3.73
2.8
2.7
16.4
19.8
mu/l
0.50
24
96
37
190
1.96
3.62
1.6
1.8
—
—
—
0
0
907
8093
1.16
3.60
1.7
1.6
18.7
20.0
nmol/l
1.71
804
6835
17
62
2.75
3.58
1.2
1.2
0.8
2.3
mmol/l
—
10
43
55
322
1.72
3.56
1.4
1.7
—
—
—
0
0
31
150
2.08
3.56
1.1
1.1
—
—
—
0
0
43
234
1.85
3.55
1.3
1.4
—
—
—
0
0
51
294
1.74
3.49
2.5
2.0
3.2
1.9
u/field
0.59
24
108
3151
30613
1.18
3.47
35.2
20.2
4.1
4.0
mmol/l
58.47
3095
29755
146
1066
1.38
3.47
1.5
1.6
117.8
276.2
titre
—
9
53
89
593
1.51
3.43
3.7
3.7
1.1
1.7
%
1.38
77
443
16
58
2.77
3.41
1.1
1.3
—
—
—
0
0
99
676
1.48
3.39
1.4
1.6
—
—
—
0
0
92
620
1.50
3.36
1.6
1.3
63.0
45.5
u/l
0.29
80
537
2799
28937
0.87
3.30
5.3
5.4
2.5
2.6
mmol/l
5.84
2503
26175
36
193
1.87
3.15
1.3
1.5
—
—
—
0
0
36
194
1.86
3.10
1.3
1.6
—
—
—
0
0
41
231
1.78
3.07
1.3
1.4
—
—
—
0
0
107
759
1.42
3.04
1.3
1.3
—
—
—
0
0
107
759
1.42
3.04
1.3
1.3
—
—
—
0
0
116
1589
0.72
3.04
2.0
1.8
—
—
—
0
0
32
170
1.89
2.90
1.3
1.4
—
—
—
0
0
32
170
1.89
2.90
1.3
1.4
—
—
—
0
0
2729
28173
0.89
2.79
4.8
4.8
4.4
4.5
mmol/l
4.75
2465
25633
29
151
1.93
2.79
1.4
1.5
0.3
0.2
nmol/l
0.50
22
118
44
261
1.69
2.79
1.1
1.1
—
—
—
0
0
44
262
1.69
2.76
1.5
1.5
—
—
—
0
0
110
801
1.38
2.73
1.2
1.2
—
—
—
0
0
29
153
1.90
2.70
1.6
1.2
—
—
—
0
0
31
168
1.85
2.66
1.2
1.3
1.5
1.0
nmol/l
0.56
22
123
39
227
1.73
2.66
1.3
1.5
—
—
—
0
0
1463
13682
1.11
2.63
2.1
2.1
93.9
93.0
pmol/l
0.28
809
7223
29
155
1.88
2.60
1.6
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
155
1.88
2.60
1.2
1.1
—
—
—
0
0
110
811
1.37
2.55
1.2
1.2
—
—
—
0
0
2708
27907
0.89
2.47
4.8
4.7
1.3
1.4
mmol/l
23.98
2433
25185
72
497
1.46
2.43
1.3
1.2
—
—
—
0
0
263
2185
1.22
2.42
2.6
2.7
10.8
10.6
g/l
0.28
238
1987
48
304
1.59
2.41
1.2
1.6
—
—
—
0
0
48
304
1.59
2.41
1.2
1.6
—
—
—
0
0
48
304
1.59
2.41
1.2
1.6
—
—
—
0
0
6
12
5.01
2.40
9.3
5.0
469.7
366.8
umol/l
—
6
12
64
434
1.48
2.37
2.3
2.2
15.5
23.9
mg/l
1.48
17
96
758
6866
1.13
2.34
1.8
1.8
1234.9
1170.2
nmol/l
0.81
590
5099
2681
25966
1.11
2.32
7.1
4.5
2.1
2.1
mu/l
0.68
2458
23235
10
35
2.86
2.30
1.1
1.1
2.0
1.8
umol/24h
—
10
35
1534
14456
1.10
2.29
2.6
2.4
—
—
—
0
0
62
421
1.48
2.29
3.3
23.2
7.6
7.5
mmol/l
0.03
49
352
18
85
2.12
2.28
1.2
1.2
—
—
—
0
0
10
36
2.78
2.20
3.1
2.3
0.2
0.5
u/field
—
10
36
60
409
1.47
2.19
1.5
1.4
—
—
—
0
0
29
165
1.76
2.18
1.4
1.2
—
—
—
0
0
30
173
1.74
2.16
1.2
1.2
34.9
19.2
u/l
0.97
25
146
59
402
1.48
2.16
1.5
1.4
—
—
—
0
0
66
460
1.44
2.16
1.4
1.2
257.4
295.3
u/ml
0.53
43
272
27
151
1.79
2.15
1.0
1.0
—
—
—
0
0
7
19
3.69
2.15
5.3
3.3
—
—
—
0
0
2761
28354
0.90
2.13
5.7
5.0
6.2
6.1
mmol/l
1.85
2469
25343
51
749
0.68
2.08
1.4
1.7
5.8
3.6
mg/l
0.60
42
541
59
406
1.46
2.07
1.5
1.4
—
—
—
0
0
43
279
1.55
2.00
1.3
1.4
—
—
—
0
0
97
734
1.33
1.97
1.5
1.9
11.9
12.7
mg/l
0.33
86
672
380
3327
1.16
1.96
2.7
2.4
5.3
7.2
ug/l
1.77
334
2890
32
194
1.65
1.96
1.7
2.1
838.9
628.4
e6/l
—
9
84
2629
27018
0.91
1.91
4.3
4.2
1.5
1.3
mmol/l
23.45
2335
24179
7
22
3.19
1.88
2.0
4.1
—
—
—
0
0
57
399
1.44
1.86
1.6
1.4
—
—
—
0
0
59
416
1.42
1.86
2.8
2.4
24.1
762.9
u/ml
0.62
59
407
568
5130
1.13
1.85
28.8
28.6
1.5
1.5
inr
0.30
79
700
17
86
1.98
1.84
1.1
1.1
—
—
—
0
0
57
400
1.43
1.84
1.6
1.4
—
—
—
0
0
57
401
1.43
1.82
1.6
1.4
—
—
—
0
0
29
177
1.64
1.75
1.4
1.5
61.8
66.5
%
0.32
24
140
378
3338
1.15
1.75
3.1
3.0
336.6
235.4
ng/l
1.82
354
3058
16
81
1.98
1.74
1.1
1.0
—
—
—
0
0
14
69
2.03
1.64
1.1
1.1
—
—
—
0
0
16
83
1.93
1.64
1.1
1.0
—
—
—
0
0
22
127
1.74
1.63
1.6
1.4
23.4
22.9
%
0.02
17
116
29
183
1.59
1.57
2.6
1.8
132.0
2340.9
u/l
—
6
61
114
918
1.25
1.51
1.4
1.4
—
—
—
0
0
10
205
0.49
1.50
1.3
1.1
—
—
—
0
0
28
178
1.58
1.48
1.2
1.7
—
—
—
0
0
28
178
1.58
1.48
1.2
1.7
—
—
—
0
0
28
178
1.58
1.48
1.2
1.7
—
—
—
0
0
28
178
1.58
1.48
1.2
1.7
—
—
—
0
0
2789
27279
1.09
1.46
29.8
16.1
61.2
74.9
ml/min/173m2
172.95
2551
22650
22
132
1.67
1.45
1.1
1.9
—
—
—
0
0
22
132
1.67
1.45
1.1
1.9
—
—
—
0
0
23
140
1.65
1.44
1.0
1.2
—
—
—
0
0
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
39
269
1.45
1.43
1.2
1.1
—
2.9
—
0
5
93
738
1.27
1.41
2.0
1.7
—
—
—
0
0
22
134
1.65
1.39
1.1
1.9
—
—
—
0
0
2583
25209
1.08
1.38
30.4
18.2
37.7
39.1
%
8.71
1619
16164
5
17
2.94
1.36
6.2
6.5
—
—
—
0
0
0
40
0.00
1.32
0.0
1.5
—
—
—
0
0
115
945
1.22
1.30
1.3
1.6
—
—
—
0
0
3121
30717
1.09
1.30
37.2
20.0
113.8
84.0
umol/l
87.53
3121
30708
50
372
1.35
1.24
3.5
3.7
58.3
58.2
%
0.01
38
226
2681
27354
0.93
1.23
7.2
6.5
41.5
40.9
mmol/mol
2.73
2459
24938
23
147
1.57
1.22
1.3
1.4
—
—
—
0
0
758
7100
1.08
1.22
1.7
1.8
20484288.1
25873821.5
pmol/l
0.10
620
5782
10
49
2.04
1.22
1.1
2.2
—
—
—
0
0
27
180
1.50
1.20
1.4
2.3
467.0
547.2
e6/l
0.42
19
158
27
183
1.48
1.13
2.5
3.3
—
—
—
0
0
8
40
2.00
1.12
1.3
1.2
—
—
—
0
0
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
22
145
1.52
1.05
1.6
1.5
1.1
2.2
%
1.03
17
121
127
1080
1.18
1.05
1.2
1.3
—
—
—
0
0
139
1192
1.17
1.05
1.5
1.8
36.6
38.3
u/l
0.40
118
1009
25
171
1.46
1.02
1.5
2.3
0.3
0.2
e9/l
0.20
19
156
27
381
0.71
1.01
1.1
1.1
—
—
—
0
0
14
83
1.69
1.01
1.4
1.5
2.3
1.9
umol/l
0.88
14
76
251
2792
0.89
1.00
1.6
1.8
1.6
1.6
%
0.09
212
2370
5
109
0.46
1.00
1.2
2.2
7066.0
19680.0
e6/l
—
5
67
312
2838
1.11
0.98
2.5
2.2
288.6
160.9
ug/g
0.98
247
2218
92
768
1.20
0.96
1.4
1.4
1.2
1.2
g/l
0.77
87
727
89
742
1.20
0.94
1.3
1.4
0.3
0.2
g/l
1.04
84
701
7
37
1.89
0.94
1.1
1.0
—
—
—
0
0
6
27
2.22
0.93
1.0
1.0
—
—
—
0
0
32
234
1.37
0.93
1.1
1.0
—
—
—
0
0
25
175
1.43
0.92
2.3
2.3
—
—
—
0
0
21
142
1.48
0.92
1.1
1.1
—
—
—
0
0
8
44
1.82
0.85
1.8
1.1
—
—
—
0
0
13
204
0.64
0.85
1.5
1.4
98.1
198.4
pmol/l
—
7
66
94
797
1.18
0.85
1.7
1.6
0.4
11.8
iu/ml
0.89
15
182
14
88
1.59
0.84
1.1
1.1
—
—
—
0
0
3101
30645
1.07
0.82
17.2
11.2
27.5
26.2
u/l
0.37
3002
29331
17
113
1.51
0.82
1.2
1.0
—
—
—
0
0
12
73
1.65
0.81
1.9
1.3
12.5
9.4
ug/l
0.96
12
73
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.4
—
—
—
0
0
17
115
1.48
0.76
1.0
1.3
—
—
—
0
0
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
61
504
1.21
0.75
1.3
1.2
—
—
—
0
0
97
1121
0.86
0.74
1.1
1.0
—
—
—
0
0
119
1044
1.14
0.73
1.4
1.6
—
—
—
0
0
14
92
1.52
0.72
1.4
1.1
—
—
—
0
0
377
4034
0.93
0.72
1.2
1.2
16.1
15.3
u/ml
0.06
121
1426
7
41
1.71
0.70
1.0
1.7
—
—
—
0
0
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
47
386
1.22
0.64
1.0
1.2
101.2
195.5
miu/ml
2.24
11
130
12
79
1.52
0.62
1.1
1.1
775.1
1635.0
miu/ml
3.61
12
79
6
101
0.59
0.62
1.3
1.4
—
—
—
0
0
36
446
0.81
0.61
1.3
1.3
—
—
—
0
0
281
2613
1.08
0.61
2.2
2.2
11.5
12.4
nmol/l
1.05
241
2256
9
138
0.65
0.60
1.3
1.2
—
—
—
0
0
17
122
1.40
0.60
1.1
1.2
—
—
—
0
0
11
72
1.53
0.59
1.5
1.1
—
—
—
0
0
8
123
0.65
0.54
2.1
2.4
1353.3
6361.6
e6/l
—
8
95
16
116
1.38
0.54
2.1
2.3
—
—
—
0
0
16
116
1.38
0.54
2.1
2.3
—
—
—
0
0
12
82
1.46
0.54
1.1
1.1
—
—
—
0
0
10
147
0.68
0.53
1.1
1.1
—
—
—
0
0
6
39
1.54
0.53
1.0
1.0
—
—
—
0
0
325
3063
1.07
0.52
1.3
1.4
—
—
—
0
0
1529
14960
1.04
0.52
5.0
5.3
3.4
3.9
ug/l
0.32
1358
13325
78
687
1.14
0.50
1.8
1.7
—
—
—
0
0
156
1431
1.09
0.50
1.3
1.3
247.0
239.2
u/ml
0.03
138
1298
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
27
218
1.24
0.46
1.1
1.2
—
—
—
0
0
24
191
1.26
0.46
1.3
1.6
—
—
—
0
0
24
191
1.26
0.46
1.3
1.6
—
—
—
0
0
13
94
1.38
0.46
1.1
1.2
—
—
—
0
0
8
121
0.66
0.45
1.1
1.1
283.6
215.6
iu/ml
—
8
121
7
50
1.40
0.45
1.1
1.8
—
—
—
0
0
14
186
0.75
0.44
1.1
1.1
—
—
—
0
0
14
186
0.75
0.44
1.1
1.1
—
—
—
0
0
14
186
0.75
0.44
1.1
1.1
—
—
—
0
0
44
376
1.17
0.44
2.5
3.8
35.5
37.6
u/ml
0.05
44
365
26
318
0.82
0.43
1.2
1.5
18.2
26.3
%
0.93
17
196
14
183
0.76
0.40
1.1
1.1
—
—
—
0
0
14
183
0.76
0.40
1.1
1.1
—
—
—
0
0
5
34
1.47
0.40
3.0
4.3
—
—
—
0
0
412
4297
0.95
0.40
1.2
1.3
40.3
38.8
iu/ml
0.06
125
1311
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
7
106
0.66
0.39
1.6
1.7
25.2
94.7
ug/l
—
7
95
67
747
0.89
0.37
4.0
3.6
32.8
30.0
mg/l
0.21
42
473
42
364
1.16
0.37
1.8
1.3
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
28
332
0.84
0.36
1.6
1.8
—
—
—
0
0
5
79
0.63
0.35
1.0
1.1
—
—
—
0
0
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
835
8556
0.97
0.34
3.1
3.2
0.9
0.8
ug/l
0.92
627
6026
10
73
1.37
0.34
1.1
1.3
—
—
—
0
0
10
133
0.75
0.33
1.5
1.7
—
—
—
0
0
1178
12002
0.97
0.33
4.4
4.6
23.1
22.0
%
1.79
641
6225
45
399
1.13
0.31
3.2
3.6
—
—
—
0
0
27
315
0.86
0.30
1.4
1.3
40772.0
107047.2
e6/l
0.77
17
223
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
12
93
1.29
0.30
1.7
1.5
—
—
—
0
0
7
56
1.25
0.29
1.0
1.3
—
—
—
0
0
36
409
0.88
0.29
3.3
4.5
301.6
343.1
umol/l
1.34
30
357
70
640
1.10
0.29
1.6
1.5
1.0
0.8
nmol/l
1.28
60
523
16
195
0.82
0.28
1.1
1.2
16.6
12.3
mmol/l
—
6
65
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
16
131
1.22
0.27
1.2
1.2
—
—
—
0
0
27
311
0.87
0.27
1.4
1.2
7.4
7.6
mmol/l
0.20
20
227
54
594
0.91
0.26
1.2
1.3
—
—
—
0
0
68
626
1.09
0.25
1.2
1.3
3.9
3.9
mmol/l
0.13
63
583
25
286
0.87
0.23
1.0
1.1
3.0
1.9
u/ml
—
9
114
5
38
1.32
0.23
1.4
1.7
—
—
—
0
0
5
38
1.32
0.23
1.0
1.9
—
—
—
0
0
223
2314
0.96
0.21
1.3
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
3.9
—
0
11
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
8
101
0.79
0.21
1.0
1.2
—
—
—
0
0
49
450
1.09
0.21
1.0
1.1
1.5
84.9
iu/ml
2.06
11
83
19
164
1.16
0.20
1.8
1.4
0.5
1.3
u/ml
0.60
13
86
422
4119
1.03
0.20
13.0
7.8
—
—
—
0
0
11
132
0.83
0.18
1.1
1.1
—
—
—
0
0
15
128
1.17
0.18
1.5
2.6
106.8
94.3
%
0.48
15
121
43
396
1.09
0.18
1.5
1.4
—
—
—
0
0
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
8
69
1.16
0.16
1.4
1.4
—
—
—
0
0
59
627
0.94
0.15
1.1
1.1
5.6
9.2
u/ml
—
5
49
524
5331
0.98
0.15
1.2
1.2
1.8
1.8
u/ml
0.02
122
1307
6
80
0.75
0.15
1.2
1.2
—
—
—
0
0
25
226
1.11
0.15
1.0
1.1
—
90.7
—
0
9
26
286
0.91
0.15
1.6
1.6
39.0
25.2
u/ml
—
5
57
24
264
0.91
0.14
1.4
1.8
—
—
—
0
0
95
914
1.04
0.12
1.2
1.2
0.5
0.8
u/ml
—
7
80
18
162
1.11
0.11
1.2
1.0
—
—
—
0
0
57
599
0.95
0.11
1.1
1.1
—
—
—
0
0
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
15
135
1.11
0.09
1.3
1.1
1.0
1.2
u/l
—
8
72
17
186
0.91
0.09
1.7
1.9
18.9
16.6
nmol/l
0.57
17
170
44
462
0.95
0.09
1.2
1.1
53.7
44.2
u/ml
—
10
39
22
237
0.93
0.09
1.0
1.1
—
—
—
0
0
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
64
1.09
0.08
1.4
1.1
77.1
90.0
%
—
7
57
10
88
1.14
0.08
1.4
2.2
1.8
1.3
ug/l
—
10
79
32
303
1.06
0.07
1.1
1.1
—
—
—
0
0
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
9
87
1.03
0.07
1.2
2.4
—
—
—
0
0
18
167
1.08
0.06
1.3
1.6
5.4
7.5
u/l
1.04
13
143
8
90
0.89
0.06
2.1
3.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
91
0.88
0.06
1.3
1.9
189.9
184.7
%
—
8
82
86
840
1.02
0.06
2.9
3.1
0.8
0.8
nmol/l
0.33
65
633
14
129
1.09
0.05
1.7
1.5
8.9
9.7
ug/l
0.12
14
110
3158
31608
0.99
0.04
42.6
24.6
4.3
4.4
e12/l
23.75
3089
30527
36
348
1.03
0.04
1.2
1.2
3.6
5.1
u/ml
0.51
17
158
3159
31617
0.99
0.04
42.6
24.6
7.3
6.9
e9/l
15.09
3091
30530
399
3964
1.01
0.04
4.5
4.8
30.6
32.8
%
3.96
273
2586
11
119
0.92
0.04
1.2
1.6
86.0
104.4
umol/l
—
5
71
81
796
1.02
0.03
1.6
1.6
15812.6
14906.8
e6/l
0.07
62
559
3159
31614
0.99
0.03
42.8
24.8
129.0
134.6
g/l
65.14
3122
31027
66
647
1.02
0.03
1.1
1.2
3.1
7.6
u/ml
—
9
101
77
783
0.98
0.03
1.7
1.6
—
—
—
0
0
35
360
0.97
0.03
1.2
1.2
2.2
3.4
u/ml
0.54
13
115
63
619
1.02
0.02
1.3
1.4
54.5
24.8
e6/l
0.29
50
482
63
619
1.02
0.02
1.4
1.4
639.5
887.2
e6/l
0.22
50
511
26
268
0.97
0.02
1.1
1.0
18.7
2.5
u/ml
—
5
89
3159
31603
1.00
0.02
42.6
24.6
244.9
239.6
e9/l
3.87
3100
30639
777
7785
1.00
0.01
1.7
1.6
1.6
1.3
mmol/l
9.76
657
6431
33
337
0.98
0.01
1.1
1.1
—
—
—
0
0
34
333
1.02
0.01
1.2
1.5
—
—
—
0
0
11
116
0.95
0.00
1.2
1.1
—
—
—
0
0
12
124
0.97
0.00
1.6
1.3
—
—
—
0
0
11
105
1.05
0.00
2.2
1.9
17.7
46.4
u/l
0.99
11
98
60
597
1.01
0.00
1.8
1.9
216.8
203.5
pmol/l
0.43
55
562
11
110
1.00
0.00
2.4
6.7
60.3
73.3
%
—
6
92
64
637
1.00
0.00
1.1
1.2
2.1
4.0
u/ml
—
6
57
20
202
0.99
0.00
3.2
3.7
—
—
—
0
0
40
402
0.99
0.00
1.7
1.5
76.9
61.9
%
2.60
29
249
5
49
1.02
0.00
4.6
3.2
46.4
41.2
umol/l
—
5
40
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
6
68
0.88
0.00
1.3
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
0.00
1.1
1.4
—
—
—
0
0
6
68
0.88
0.00
1.2
2.0
195.5
209.2
%
—
6
60
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_URINARY_TRACT – Malignant neoplasm of urinary organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).